We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Researchers Will Have Ready Access to Molecular Diagnostics Expertise at the AACC Clinical Lab Expo

By LabMedica International staff writers
Posted on 30 Jul 2013
Print article
Image: Nebsolutions expertise promotes molecular diagnostic development (Photo courtesy of New England Biolabs).
Image: Nebsolutions expertise promotes molecular diagnostic development (Photo courtesy of New England Biolabs).
Biotech and other life science researchers will be able to consult with a team of molecular diagnostics (MDx) experts at the AACC (American Association for Clinical Chemistry) Clinical Lab Expo in Houston (TX, USA), from July 30-August 1, 2013.

The New England Biolabs (Ipswich, MA, USA) NEBsolutions team of experts will be available at booth 4463 during the Lab Expo meeting. The team is in place to direct access to expertise in enzymology, supply logistics, custom formulations, packaging, and kit development and to maximize access to New England Biolabs' catalogue of high-quality reagents. New England Biolabs provides reagents for a variety of MDx applications, such as sample preparation, PCR, RT-PCR, isothermal amplification, methylation detection, and library preparation for next generation sequencing.

NEBsolutions, a dedicated team within the New England Biolabs framework, comprises 110 PhDs, more than half with greater than 10 years of tenure at New England Biolabs. They provide the highest level of support to meet the specific needs of New England Biolabs' OEM and customized product customers. The NEBsolutions team excels at meeting aggressive timelines and offers rapid lead-times. This includes leveraging the capabilities of the entire company to help customers achieve their goals. The NEBsolutions team will work to optimize reagent formulation, function, and manufacturing process, resulting in an optimized product while minimizing cost.

"New England Biolabs has been supplying high-quality reagents to the molecular diagnostics community since 1995," said John Pelletier, director of NEBsolutions. "Through the NEBsolutions team, you gain access to NEB’s broad array of resources, including the deep scientific know-how to functionally optimize your product, comprehensive experience in the manufacturing of high-quality products, and extensive experience in supply chain management and risk mitigation. Our quality-by-design approach ensures product performance and consistency that surpass customer needs."

Related Links:
New England Biolabs
NEBsolutions


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Aspergillus Test
REALQUALITY Aspergillus

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.